UPC stock icon

Universe Pharmaceuticals
UPC

$3.91
9.83%

Market Cap: 14.3M

 

About: Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Employees: 225

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 0

50% more funds holding

Funds holding: 2 [Q4 2023] → 3 (+1) [Q1 2024]

0.14% less ownership

Funds ownership: 0.18% [Q4 2023] → 0.04% (-0.14%) [Q1 2024]

80% less capital invested

Capital invested by funds: $12K [Q4 2023] → $2.42K (-$9.62K) [Q1 2024]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Research analyst outlook

We haven’t received any recent analyst ratings for UPC.

Financial journalist opinion